Anzeige
Mehr »
Login
Donnerstag, 23.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
InnoCan Pharma: Jetzt in die Doppel-Chance investieren?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14XMD | ISIN: CA03879J1003 | Ticker-Symbol: I9DN
Tradegate
23.05.24
11:16 Uhr
3,200 Euro
+0,054
+1,72 %
1-Jahres-Chart
ARBUTUS BIOPHARMA CORPORATION Chart 1 Jahr
5-Tage-Chart
ARBUTUS BIOPHARMA CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
3,1763,24812:11
3,1783,24812:07

Aktuelle News zur ARBUTUS BIOPHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiArbutus Biopharma Corp - 8-K, Current Report4
MiArbutus Biopharma Corporation: Arbutus to Present Imdusiran Data at EASL Congress 20248
FrUS STOCKS Tilray Brands, Arbutus Biopharma, Coinbase40
FrArbutus up after investor Whitefort urges co to stop share sales, find partner10
FrInvestor Whitefort urges Arbutus Biopharma to halt stock sales, find partner8
07.05.Arbutus Biopharma Corporation: Arbutus to Participate in Two Upcoming Investor Conferences5
03.05.Earnings call: Arbutus Biopharma outlines progress in HBV clinical trials8
02.05.Arbutus Biopharma Corp - 10-Q, Quarterly Report3
02.05.Arbutus Biopharma GAAP EPS of -$0.10 beats by $0.01, revenue of $1.53M misses by $1.19M8
02.05.Arbutus Biopharma Corporation: Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024113WARMINSTER, Pa., May 02, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) ("Arbutus" or the "Company"), a clinical-stage biopharmaceutical company leveraging its extensive virology...
► Artikel lesen
02.05.Arbutus Biopharma Corp - 8-K, Current Report4
01.05.Arbutus Biopharma Q1 2024 Earnings Preview9
18.04.Arbutus Biopharma Corporation: Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update10
04.04.Arbutus Vs. Moderna Patent Dispute Over Covid-19 Vaccine Gets Response From Judge44
04.04.Arbutus, Genevant gain an edge in COVID patent scrap with Moderna24
04.04.Arbutus Biopharma Reports Claim Construction Ruling In Patent Infringement Lawsuit Against Moderna14
04.04.Arbutus Biopharma Corporation: Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna22
04.04.Arbutus Biopharma Corp - 8-K, Current Report4
03.04.Arbutus Stock Soars 20% After Court Rules Against Moderna In Covid Vaccine Patent Claim34
03.04.Moderna shares fall after judge sides with Arbutus in patent fight38
Seite:  Weiter >>
43 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1